Gemzar
Gemzar (gemcitabine) is a nucleoside metabolic inhibitor (chemotherapy agent) that works by killing cancer cells and preventing them from dividing and growing.
Dosage by Body Weight
Gemzar is administered strictly intravenously by a medical professional. Standard dosing is determined individually based on Body Surface Area (BSA) in mg/m² rather than fixed body weight, and depends on the specific cancer type and patient blood cell counts.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy in pediatric patients have not been established. Use is highly restricted and subject to pediatric oncology protocols.
- Body Weight
- 5-7 kg
- Dose
- Requires BSA calculation
- Frequency
- Consult oncologist
- Tracking Notes
- Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance.
- Body Weight
- 8-10 kg
- Dose
- Requires BSA calculation
- Frequency
- Consult oncologist
- Tracking Notes
- Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance.
- Body Weight
- 11-15 kg
- Dose
- Requires BSA calculation
- Frequency
- Consult oncologist
- Tracking Notes
- Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance.
- Body Weight
- 16-20 kg
- Dose
- Requires BSA calculation
- Frequency
- Consult oncologist
- Tracking Notes
- Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Not applicable | Safety and efficacy in pediatric patients have not been established. Use is highly restricted and subject to pediatric oncology protocols. |
| 5-7 kg | Requires BSA calculation | Consult oncologist | Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance. |
| 8-10 kg | Requires BSA calculation | Consult oncologist | Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance. |
| 11-15 kg | Requires BSA calculation | Consult oncologist | Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance. |
| 16-20 kg | Requires BSA calculation | Consult oncologist | Chemotherapy dosing must be calculated strictly based on Body Surface Area (BSA) and individual patient tolerance. |
Formulation
Intravenous InjectionLyophilized Powder for Reconstitution
Purpose
First-line treatment for locally advanced or metastatic pancreatic cancer, and used in combination therapies for non-small cell lung cancer, breast cancer, and ovarian cancer.
Generic Name
GemcitabineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.